Utilization of Oncotype DX in an Inner City Population: Race or Place?
Oncotype DX, a 21-gene-array analysis, can guide chemotherapy treatment decisions for women with ER+ tumors. Of 225 ER+ women participating in a patient assistance trial, 23% underwent Oncotype DX testing: 31% of whites, 21% of blacks, and 14% of Hispanics (P=0.04) were tested. Only 3 white wome...
Saved in:
Main Authors: | Amber A. Guth, Susan Fineberg, Kezhen Fei, Rebeca Franco, Nina A. Bickell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2013/653805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients
by: Matthew G. Hanna, et al.
Published: (2017-01-01) -
The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
by: Michał Jarząb, et al.
Published: (2024-10-01) -
Dynamic Analysis of a Rotor-Bearing-SFD System with the Bearing Inner Race Defect
by: Junhong Zhang, et al.
Published: (2017-01-01) -
Performance evaluation of the Qiagen BK virus ASR on the NeuMoDx system
by: Amorce Lima, et al.
Published: (2025-02-01) -
Understanding and utilizing the inner bonds of process tensors
by: Moritz Cygorek, Erik M. Gauger
Published: (2025-01-01)